Hannah Kuchler

14 results

A potential antiviral drug for coronavirus has disappointed scientists and investors who had high hopes for remdesivir, according to draft documents published accidentally by the World Health Organisation.

A potential antiviral drug for the coronavirus has flopped in its first randomised clinical trial, disappointing scientists and investors who had high(...)

A coronavirus drug developed by Gilead Sciences had shown positive results in a clinical trial

Wall Street shares are on track for a higher opening on Friday after a report suggested a coronavirus drug developed by Gilead Sciences had shown posi(...)

Johnson & Johnson said it had discovered a potential vaccine candidate and was teaming up with the US government to invest $1 billion (€900 million) in its development, expecting to start testing in humans by September.

Two US healthcare companies have brought hope in the race to fight coronavirus, with Johnson & Johnson announcing a potential vaccine that could b(...)

Scientist Xinhua Yan works in the lab at Moderna in Cambridge, MA.  Photograph: David L. Ryan/The Boston Globe

Juan Andres woke up three times during the night after putting his precious vials of vaccine on the back of a delivery lorry. In late February, Modern(...)

Jennifer Doudna: “On the one hand, it sounds very profound and potentially very scary to be editing the human population. But it takes time and it doesn’t happen overnight”

Jennifer Doudna wears her responsibility lightly. The scientist who co-discovered Crispr does not appear to be weighed down by the burden of her creat(...)

Judge Thad Balkman ruled that the world’s largest healthcare company had caused a “public nuisance” in the state of Oklahoma and ordered it to pay $572 million (€515 million)

A US judge on Monday ordered Johnson & Johnson to pay $572.1 million (€515 million) to the state for its part in fuelling an opioid epidemic by de(...)

Pfizer is trying to focus its business around more high value, innovative medicines, including spinning off its consumer unit

Pfizer is spinning off its off-patent and generics business UpJohn, and combining it with generic drugmaker Mylan to create a giant off-patent group w(...)

Pfizer has been trying to reposition itself as a smaller company focused on more innovative medicines and vaccines.

Pfizer is expected to announce on Monday that it will combine its off-patent assets with Mylan’s $10 billion (€9 billion) generics business in a stock(...)

The Lumi system includes a video monitor so parents can watch their baby through the app anywhere in the world

Google’s life sciences sister company Verily has created a baby-monitoring system based around “smart nappies”, working with Procter & Gamble’s Pa(...)

Laura Deming: ‘The idea was to starve a worm, mutate it, and then laser its gonads off, which increases the worm lifespan by 60 per cent’

Laura Deming is early for the interview in the restaurant in San Francisco’s hip Mission district, bent over a book. Bathed in the light streaming thr(...)

  • 1
  • 2
  • Next
  • Last »